Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas (Q43099584)

13 November 2017

title

Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas (English)

1 reference

13 November 2017

1 reference

Hildegard Janouschek

2

0 references

Paul Cumming

8

object named as

Paul Cumming

1 reference

13 November 2017

9

Christoph Hiemke

1 reference

13 November 2017

10

Frank Rösch

1 reference

13 November 2017

Ingo Vernaleken

1

1 reference

13 November 2017

Mardjan Raptis

3

1 reference

13 November 2017

Sandra Hellmann

4

1 reference

13 November 2017

Tanja Veselinovic

5

1 reference

13 November 2017

Anno Bröcheler

6

1 reference

13 November 2017

Christian Boy

7

1 reference

13 November 2017

Wolfgang M Schäfer

11

1 reference

13 November 2017

Gerhard Gründer

12

1 reference

13 November 2017

publication date

15 April 2010

1 reference

The International Journal of Neuropsychopharmacology

13 November 2017

published in

1 reference

13 November 2017

volume

13

1 reference

13 November 2017

issue

7

1 reference

13 November 2017

page(s)

951-960

1 reference

Neuroreceptor imaging studies in schizophrenia.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Time course of central nervous dopamine-D2 and 5-HT2 receptor blockade and plasma drug concentrations after discontinuation of quetiapine (Seroquel) in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET--a comparison to the equilibrium analysis

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Striatal and extrastriatal D2/D3-receptor-binding properties of ziprasidone: a positron emission tomography study with [18F]Fallypride and [11C]raclopride (D2/D3-receptor occupancy of ziprasidone).

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

On the origin of cortical dopamine: is it a co-transmitter in noradrenergic neurons?

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Imaging studies - differential action of typical and atypical antipsychotics in a network perspective

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Pharmacokinetics and time-course of D(2) receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Significant dissociation of brain and plasma kinetics with antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

(-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Regional distribution of monoamines in the cerebral cortex and subcortical structures of the rhesus monkey: concentrations and in vivo synthesis rates

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Striatal vs extrastriatal dopamine D2 receptors in antipsychotic response--a double-blind PET study in schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Striatal and extra-striatal D(2)/D(3) dopamine receptor occupancy by quetiapine in vivo. [(123)I]-epidepride single photon emission tomography(SPET) study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Endogenous dopamine limits the binding of antipsychotic drugs to D3 receptors in the rat brain: a quantitative autoradiographic study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Automated analysis of quetiapine and other antipsychotic drugs in human blood by high performance-liquid chromatography with column-switching and spectrophotometric detection

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Limbic selectivity of clozapine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Potentials and pitfalls using high affinity radioligands in PET and SPET determinations on regional drug induced D2 receptor occupancy--a simulation study based on experimental data

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Quetiapine extended-release versus immediate-release formulation: a positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Simplified reference tissue model for PET receptor studies.

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

IBZM SPECT imaging of striatal dopamine-2 receptors in psychotic patients treated with the novel antipsychotic substance quetiapine in comparison to clozapine and haloperidol

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Occupancy of striatal and extrastriatal dopamine D2 receptors by clozapine and quetiapine

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

No regional difference in dopamine D2 receptor occupancy by the second-generation antipsychotic drug risperidone in humans: a positron emission tomography study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

N-[11C]methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [18F]fallypride PET study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: a PET study

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

Extrastriatal and striatal D(2) dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS1461145710000374

7 January 2021

10.1017/S1461145710000374

Identifiers

DOI

1 reference

13 November 2017

1 reference